Changeflow GovPing Healthcare & Life Sciences NCT07544446: Randomised Study of Psycho-Oncolog...
Routine Notice Added Final

NCT07544446: Randomised Study of Psycho-Oncological Initial Consultation for Cancer Patients

Favicon for changeflow.com ClinicalTrials.gov Studies
Detected
Email

Summary

NCT07544446 is a randomised controlled trial registered on ClinicalTrials.gov investigating whether an initial consultation with a psycho-oncological specialist reduces anxiety, depression, and improves quality of life in cancer patients compared to standard treatment alone. The study, developed by patients, will follow 276 participants over 6 months with assessments at baseline, 3 months, and 6 months. The intervention group receives a detailed initial consultation with a psycho-oncology specialist plus standard treatment; the control group receives standard treatment only. The study is being conducted simultaneously at multiple hospitals.

“This study investigates whether an initial consultation with a psycho-oncological specialist reduces anxiety and depression, improves quality of life, and whether patients subsequently make greater use of support services.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 657 changes logged to date.

What changed

NCT07544446 is a newly registered randomised controlled trial examining the impact of an initial psycho-oncological consultation on cancer patients. Participants are randomised to receive either an initial consultation with a psycho-oncology specialist plus standard treatment, or standard treatment alone. The study evaluates anxiety, depression, quality of life, and subsequent use of support services at 3-month and 6-month intervals.

Healthcare providers and researchers studying psycho-oncology interventions should note this patient-developed trial design. Hospitals conducting similar psychosocial oncology programs may find the study outcomes relevant to their support service utilisation patterns. The randomised design and 6-month duration provide moderate-quality evidence potential for future clinical practice guidelines.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

What Impact Does an Initial Psycho-oncological Contact Have on People With Cancer?

N/A NCT07544446 Kind: NA Apr 22, 2026

Abstract

When diagnosed with cancer, patients or their relatives may, if they wish, on the recommendation of the treatment team and/or in cases of high stress, seek psycho-oncological support.

This study investigates whether an initial consultation with a psycho-oncological specialist reduces anxiety and depression, improves quality of life, and whether patients subsequently make greater use of support services.

Participants will be randomised, meaning they will be assigned to groups at random to ensure that the results are comparable. In the intervention group, participants will receive a detailed initial consultation with a psycho-oncology specialist and standard treatment. In the control group, participants receive standard treatment. To gather results, questionnaires are administered at regular intervals (at the start, after 3 and 6 months). The study lasts a total of 6 months.

The study was developed by patients. It is being conducted simultaneously at several hospitals.

Conditions: Cancer, Psycho-Oncology

Interventions: initial psycho-oncological contact, Standard

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Docket
NCT07544446

Who this affects

Applies to
Healthcare providers Patients Clinical investigators
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Psychosocial oncology research Cancer patient support
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Public Health Pharmaceuticals

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!